The effect of mild traumatic brain injury on cytokine expression in brain tissue by Greene, Ryan M.
  
 
THE EFFECT OF MILD TRAUMATIC BRAIN INJURY ON CYTOKINE EXPRESSION IN 
BRAIN TISSUE 
 
 
BY 
RYAN MICHAEL GREENE 
 
 
 
 
 
 
 
THESIS 
Submitted in partial fulfillment of the requirements 
for the degree of Master of Science in Kinesiology 
in the Graduate College of the 
University of Illinois at Urbana-Champaign, 2011 
 
 
Urbana, Illinois 
 
  Master’s Committee:  
    
        Professor Jeffrey A. Woods, Director of Research  
     Professor Kenneth R. Wilund 
 ii   
 
Abstract 
 Previous research suggests that mild traumatic brain injury (mTBI) results in significant 
cognitive and behavioral learning deficit, as well as long-term depressive like behavior in mice.  
mTBI has been identified as a major initiating event in long-term depressive-like behavior and 
early fatality observed in soldiers returning from conflicts in Iraq and Afghanistan, as well as 
athletes in amateur and professional sport. Purpose- The purpose of the proposed study was to 
investigate brain tissue for the presence of proinflammatory cytokines as a potential mechanism 
to explain long-term depressive-like behavior seen in previous mTBI studies.  Methods- Male 
ICR mice (n=16) were randomly assigned to one of 2 treatment groups:  mTBI (n=8) and Sham 
(n=8).  Mice were anaesthetized and given mTBI by dropping a weight similar to previously 
measured body weight to an area located between the ear and the eye from a height of two feet.  
Baseline behavioral data was measured for both treatment groups for 8 days prior to treatment.  
Following mTBI, at the 48 and 72 hour time point, Roto-rod testing was conducted to ensure any 
differences in baseline behavioral deficit in either treatment group was not do to motor cortex 
impairment.  Mice were sacrificed 7 days following treatment and tissue was tested for presence 
of proinflammatory cytokines detected via RtPCR.  Results- There was only a significant 
treatment effect seen in the expression of proinflammatory cytokine TNF-α.  All other 
proinflammatory cytokine expression had a high degree of variability between both groups.  
Roto-rod data confirmed there was no motor cortex deficit involved in deficit in behavioral 
measurements gathered following treatment.  Conclusion- These circumstantial data suggest that 
proinflammatory cytokines may play a role in instigating long-term depressive like behavior by 
infiltrating neurological tissue in individuals afflicted with mTBI, but the weight drop model 
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used to inflict mTBI was too mild to induce large scale significant changes in pro-inflammatory 
cytokines or long-term behavioral depression.  
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CHAPTER 1: INTRODUCTION 
Mild traumatic brain injury (mTBI) is the principal result from falls, acts of war and 
violence, and sport-related injury (McAllister, 1992). Presently, more than 5.3 million people are 
survivors of traumatic brain injuries.  More than 75% of injuries considered mTBI occur mainly 
while individuals are participating in sporting and leisure activities (McAllister, 1992).   Sports-
related brain injuries occur to 1.6-3.8 million individuals annually.  The total direct and indirect 
cost for these injuries has been projected to surpass 60 billion dollars (Elder & Cristian, 2009) 
(Aubry, et al., 2002).  In addition, a recent study has suggested a large percentage of soldiers 
returning of Operation Iraqi Freedom (OIF) and Operation Enduring Freedom (OEF) have or 
should be diagnosed with mTBI by the time they return from deployment (Elder & Cristian, 
2009) (Vanderploeg, Belanger, & Curtiss, 2009) (Koren, Norman, Cohen, Berman, & Klein, 
2005).  It is believed that a large percentage of veterans returning from service who have 
suffered mTBI will experience long-term health deficit of some type and affect their inability to 
return to active service or effectively assimilate back into civilian society (Elder & Cristian, 
2009) (Vanderploeg, Belanger, & Curtiss, 2009) (Koren, Norman, Cohen, Berman, & Klein, 
2005).   
A discrepancy encountered in the current mTBI literature is lack of a universally 
accepted definition of mTBI.  For the most part, clinicians define mTBI as any injury that 
manifests itself by at least one of the following: (1) any period of loss of consciousness, (2) any 
loss of memory for events immediately before or after the incident, (3) any alteration of mental 
state at the time of the accident (dizziness, disorientation, confusion), and (focal neurological 
deficits, which may or may not be transient, but when the severity of the accident does not 
exceed the following; a) loss of consciousness of 30 minutes or less; (b) after 30 minutes, an 
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initial Glasgow Coma Scale score of 13-15; and (c) posttraumatic amnesia not greater than 24 
hours (Weighill, 1983) (Slagle, 1990).  Figure 1 describes the wide variety of diagnostic criterion 
that contribute to this discrepancy.  
 
Figure 1. (Busch & Alpern, 1998) 
 It is proposed that most of the impairment in mental functions experienced post-mTBI 
have a common biological origin in the form of inflammation within the brain.  It is believed that 
these deficits are exacerbated in stressful conditions such as combat (Busch & Alpern, 1998).  
Indeed, recent research has identified a role for brain proinflammatory cytokine expression in 
mediating changes in behavior and cognition (Milman, Rosenberg, Weizman, & Pick, 2005).  An 
untested but likely mechanism for this post morbid increase in behavioral and cognitive disorders 
is the infiltration of pro-inflammatory cytokine action in the brain.  The proposed mechanism 
involves cytokine-induced activation of critical tryptophan (Trp) catabolizing enzyme 
indoleamine 2,3-dioxygenase (IDO).  IDO would theoretically convert Trp to a neurotoxic 
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Rattock, 1989) definition as a cerebral concussion
that occurs when a person sustains a head injury but
shows no evidence of structural brain damage is con-
cise but general; as is Rutherford's (1989), defining
concussion as an acceleration/deceleration injury to
the head almost always associated with a period of
amnesia, and followed by a characteristic group of
symptoms such as headache, poor memory, and ver-
tigo. Unfortunately, these definitions are not quanti-
fiable.
The Glasgow Coma Scale (GCS) is the most
commonly used instrument to measure severity of in-
jury and is typically given by emergency personnel
either at the site of the injury or in the hospital. It
classifies injuries into three groups of severity (mild,
moderate, severe) using a scale of 0-15, assessing
verbal, motor, a d ocular respo ses t  simple stimuli.
The use of loss of consciousness (LOG) as an indi-
cation of degree of injury is controversial (Tucker,
1994). Typically, MTBI is defined with LOC of less
than 20 or 30 minutes (Evans, 1996; Rimel et al,
1981). It is argued that injury can occur without the
loss of consciousness (Cantu, 1992; Evans, 1996;
Rutherford et al, 1977; Stauss and Savitsky, 1934).
The third most common indicator of degree of injury
is posttraumatic amnesia (PTA), a period of confu-
sion, disorientation, and inability to recall events, se-
quence time, or learn new information (McAllister,
1992). Although PTA was not reported in all studies,
it can be assessed with the Galveston Orientation
and Amnesia Test (Levin et al., 1982). It is worth not-
ing that the correlation between the different meas-
ures of severity of injury is low (Cantu, 1992).
As for the criteria for severity of brain injury
used in all of the studies discussed, for LOC, 1 study
used less than 5 minutes, 3 studies used less than 15
minutes, 7 studies used less than 20 minutes, 1 less
than 30 minutes, and 1 less than 1 hour. Even though
there is some variability, any LOC over 1 hour is most
likely the result of a more severe injury. The second
most common criterion used was the GCS, with a
score of 13 or above used in 7 studies and a score of
12-15 in 2 studies. Eight of the studies included PTA,
but it was highly variable (< 1 hour, < 2 hours, and
< 24 hours). Five studies did not use any of the above
criteria to assess for severity of injury. As an adjunct
to the above, all of the studies employed further
evaluation of injury such as neuroimaging, neuropsy-
chological testing, symptom checklists, or interview-
ing. (For assessment of MTBI see Table I.)
Assessment of Depression
It has been shown that those with a head injury
are capable of completing self-report scales, which
correlate well with data obtained from relatives (Kin-
sella et al., 1988). Assessment of depression varied
considerably in the reviewed studies, with some of
the studies employing more than 1 type of assess-
ment. Six used the Hamilton Rating Scale for De-
pression (HRSD), 2 used the Self Rating Depression
Scale (SRDS), 2 used the Beck Depression Inventory
Table I. Assessment of Mild Traumatic Brain Injury
Authors
Novack et al., 1984
Saran, 1985
Atteberiy-Bennett et al., 1986
Diamond et al., 1988
Saran, 1988
Schoenhuber and Gentilini, 1988
Mobayed and Dinan, 1990
Leininger et al., 1991
O'Carroll et al., 1991
Alexander, 1992
Bohnen, Jolles et al., 1992
Bohnen, Twijnstra, and Jolles, 1992
Dinan and Mobayed, 1992
Fedoroff a al., 1992
Jorge, Robinson, Arndt et al., 1993
Gfeller et al., 1994
Fann et al., 1995
King, 1996
Parker and Rosenblum, 1996
Assessment
PTA < 24 h
LOC < 20 min
GCS 13-15
LOC < 20 min
LOC < 20 min
LOC 20 min, GCS 13-15
LOC < 20 min
LOC or PTA < 20 min, GCS 13-15
GCS 13-15
LOC 15 min, PTA < 2h
LOC 15 min, GCS 13-15, PTA < 1 h
LOC 15 min, GCS 13-15, PTA < 1 h
LOC < 20 min
GCS 12-15
GCS 12-15
LOC < 1 h
LOC 30 min, GCS 13-15, PTA 24 h
PTA < 24 h
LOC < 5 min
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quinolinic acid (QA), thus reducing serotonin synthesis and creating an imbalance between 
serotonin and QA.  This would result in cognitive impairment and depressive like symptoms.  
Such effects have been shown before with work from our lab and others following mTBI 
(Milman, Rosenberg, Weizman, & Pick, 2005), but confirmation of any cytokine action in 
neurological tissue have yet to be discovered.   
Purpose 
 It has been widely accepted that TBI, specifically mTBI, can lead to a host of physical, 
cognitive, and emotional deficits both acutely following insult, as well as long term depressive 
like behavior.  The current study embraces a multidisciplinary mechanistic approach to 
understanding the symptom burden experienced by people suffering from mTBI to examine if 
pro-inflammatory cytokine expression in brain tissue may in fact be a culprit in depressive like 
behavior seen in time points far removed from mTBI.  
Specific Aim 
To examine the effect of mTBI administered to mice and the potential expression of pro-
inflammatory cytokine expression in brain tissue that may be the cause of depressive like 
behavior previously seen following mTBI.   
Hypothesis 
Following mTBI, expression levels of pro-inflammatory cytokines in brain tissue will be 
significantly elevated compared to non-mTBI controls.   
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CHAPTER 2: LITERATURE REVIEW 
mTBI is a result from a direct or indirect force applied to the head that produces 
neuropathologic changes to brain tissue (Aubry, et al., 2002).  Despite the lack of structural 
changes to cerebral tissue, the functional alterations in brain tissue may manifest in a variety of 
phenotypes (Giza & Hovda, 2001) (Fann, Katon, Uomoto, & Esselman, 1995).  Those who have 
suffered from mTBI commonly report deficits in the ability to maintain balance and exhibit 
decreases in neurocognitive functioning (Broglio & Puetz, 2008).   
Even mild trauma to the brain can produce neuropathologic changes similar, if not greater 
in quantity in come cases, to traumatic brain injuries (McBeath & Nanda, 1994).  Many studies 
have investigated damage to the brain after concussion and recent research has contradicted 
previous belief in the sense that the greater amount of damage in mTBI cases is not a result of 
direct impact to cranial bones, but rather inertial forces on the brain (acceleration and 
deceleration within the cranium) as a result of an impact (Bond, 1984).  Research has shown that 
direct impact is not necessary for significant brain damage to occur seen in many mTBI cases.  
Previous research has shown that uniform compressive stresses are well tolerated by neural 
tissue.  Shearing forces can fracture and stretch axons in the brain to the point that cell bodies of 
axons are compromised (Cantu, 1992).  This disruption of axon cell bodies can interrupt blood 
flow to the brain due to tearing of blood vessels leading to significantly greater brain damage 
(Cantu, 1992).  Povlishock and Coburn (1989) speculate that diffuse axonal damage in subjects 
that have suffered significant head injury is the main contributor to the disconnection seen 
between the Central Nervous System (CNS) and many peripheral organs, including endocrine, 
which constitute the morphological abnormalities seen in both behavioral and typical baseline 
functioning following mTBI.   
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The impact on neurocognitive dysfunction and motor function deficit are well 
documented.  The literature leading to present day understanding has described that a decrease in 
performance in either area are believed to be the result of divergent physiological mechanisms 
rather than similar (McAllister, 1992). 
The focus of this review will outline the mechanisms by which mTBI effects cognitive 
and motor, behavior, and endocrine function with hopes to establish a link between mTBI related 
deficits and the inflammatory effects potentially present in brain tissue that may lead to 
previously described depressive like behavior following neurological insult such as mTBI.   
mTBI and motor function deficit 
 The impact of mTBI on cognitive and motor function has been well documented.  It has 
been previously established that individuals with decreased cognitive functioning also 
demonstrate decreased motor function, mainly seen as a deficit in locomotor and postural control 
(Guskiewicz, et al., 2003).  The dichotomy exists in the fact that the decrease in performance in 
both areas have been previously described as separate processes, but increasing evidence is now 
suggesting that the separation of cognitive and motor function in fact share the same neural 
mechanisms (Guskiewicz, et al., 2003) (De Monte, 2005).  The association between cognitive 
and motor functioning deficit due to mTBI has been strengthened by research examinations of 
dual task performance.  Catena et al. (2007) showed that there is a profound correlation in deficit 
seen in motor and cognitive functioning.  Catena showed that the addition of a secondary 
cognitive task when paired with a motor function task increased the gait instability in mTBI 
patients when compared to healthy controls (Catena, van Donkelaar, & Chou, 2007).  This deficit 
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was contributed to a decrease in attentional resources towards the motor function task due to 
mTBI. 
 De Monte et al. (2005) was one of the early studies that drew a correlation between the 
mechanism for motor and cognitive deficit following mTBI.  This study was aimed to investigate 
the acute effects of mTBI on a motor performance (finger tapping) and word repetition dual task 
in order to determine working memory impairment in mTBI (De Monte, 2005).  Patients with 
mTBI competed fewer correct taps in 10 seconds as well as fewer correct repetitions of words 
asked to be memorized than patients with non-mTBI related injuries.  These results confirmed 
the view that there may be a significant correlation between motor and cognitive functioning 
most notably linked following mTBI.   
 In 2008, Broglio et al. conducted a study to investigate whether mTBI resulted in a 
change in association between motor and cognitive function.  This approach differed from the 
literature discussed previously because Broglio et al. examined motor and cognitive functioning 
following mTBI together rather than separately.  They hypothesized that there would be a link 
between cognitive and motor control functioning in individuals who suffered from mTBI.  In 
order to assess this correlation, Broglio et al. tested cognitive and motor function pre and post 
mTBI by examining 36 athletes prior to and 24 hours post mTBI insult.  From this investigation, 
Broglio et al. (2008) reported there was in actuality a significant association between cognitive 
and motor function indices following mTBI.  In the non-injured state, Broglio et al. found that 
motor and cognitive functionality operated independently of one another.  Following cerebral 
insult, the functional capacity of both processes appeared strongly associated.   
 7   
 Based on these findings, Broglio et al. (2008) concluded that mTBI adversely affects dual 
task performance.  This may be attributed to the belief that mTBI reduces the finite attentional 
resources available to perform simultaneous tasks.   
mTBI and behavior 
 Few studies to date have examined the relationship between behavioral and psychological 
effects caused by mTBI (Fann, Katon, Uomoto, & Esselman, 1995).  The pathological conditions 
that occur most often following mTBI are often grouped together and discussed under the label 
of Post-concussion Syndrome (PCS) (Mittenberg, Zielinski, & Fichera, 1993).  Most commonly 
reported symptoms are differentiated into either  physical, cognitive, or psychological in nature.  
Depression lasting 3-9 months following insult is the most frequently reported symptom 
following mTBI.  Unfortunately, many individuals who suffer from such depressive-like 
behaviors or PCS often go undiagnosed for several reasons: (1) many patients are sent home 
from the hospital or emergency room following mTBI and are never contacted again for follow 
up treatment; (2) patients may be considered to be over-expressing symptoms to deceive and 
acquire medication an (3) many symptoms of depressed patients may be less pronounced in some 
mTBI individuals compared to others due to an overall personality flattening (Mittenberg, 
Zielinski, & Fichera, 1993) (Fann, Katon, Uomoto, & Esselman, 1995) (Catena, van Donkelaar, 
& Chou, 2007).   
 Alexander (1992) compared a group of individuals who suffered mTBI to baseline non-
mTBI controls and found that individuals in the mTBI groups (59%) complained of poor 
concentration, memory, and continual depressed mood as well as a significant deficit in 
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cognitive functionality.  Alexander also found that 39% of mTBI patients showed significant 
psychomotor retardation.   
 Ettlin et al. (1992), in a study of individuals suffering from mTBI following motor 
vehicle accidents found that 42% of mTBI patients reported symptoms of depression in overall 
mood, loss of energy, and a significant lack of motivation to perform routine daily activities.   
 Previous work has also shown that depression or depressive like symptoms following 
mTBI has been linked to many behavioral deficits compared to pre-mTBI functioning that can 
lead to disability, loss of work, guilt, anger, pain, chronic frustration, and lifestyle changes 
(Gfeller, Chibnall, & Duckro, 1994).  A relationship between cognitive deficit and incidence of 
depression following mTBI has also been elucidated.  This previous research has lead to the 
conclusion that mTBI may be a triggering event for a set of pathophysiological changes and a 
greater likelihood of concomitant depressive episodes in the mTBI population compared to 
normal individuals (Gfeller, Chibnall, & Duckro, 1994).   
Researchers also hypothesize that the shearing forces that occur during a mTBI may 
produce a stem of anatomical, physiological, and chemical changes that may evoke behavioral 
pathology so that the stressors that may not ordinarily trigger a pathological state may then have 
the ability to do so but the mechanisms are not yet well defined.  mTBI may then be able to 
produce a direct pathological state from stressors associated with mTBI, such as musculoskeletal 
pain, inflammation, and cognitive dysfunction.   Stressors that did not previously have potent 
enough effect to have significant psychological effect may then induce depression in mTBI 
sufferers (Gfeller, Chibnall, & Duckro, 1994).   
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In 2005, Milman et al. described the effect of mTBI on persistent cognitive and 
behavioral deficit.  Their work further reiterated the belief that deficits in learning and memory 
are common repercussions of mTBI in both humans and mice.  His work reflected these findings 
by exhibiting impairments in memory and learning assessed by passive avoidance and swim T-
maze tasks.  Mice that suffered mTBI showed worse performance than control mice in the 
passive avoidance task.  Interestingly, there seemed to be a delay in the onset of deficit in this 
memory task of nearly 30 days.  In the forced swim test, behavioral abnormality could be seen as 
soon as 7 days and as long as 69 days following injury.  These results suggest that following 
mTBI, there is a tendency to develop a depressive-like state, possibly leading to earlier fatigue in 
injured animals and significant memory deficit.   
This work reflected similar preliminary findings from unpublished data from our lab, as 
seen in figures 2 and 3 below, regarding behavioral deficit following mTBI conducted prior to 
beginning the current experiment.  Taste Preference Testing was used to measure actual intake of 
sucrose-containing liquid compared to water, which is a symptom of depressive-like behavior, 
called anhedonia.   
Other findings found in unpublished data from our lab similar to research described 
previously by Millman et al. (2005) are presented in Figure 2 below to certify that the model we 
used to inflict mTBI in this experiment would result in cognitive deficit expressed by Morris 
Water Maze (MWM).  Figure 3 expresses deficit in passive avoidance tasks such as the Tail 
Suspension Test (TST) found in unpublished data from our lab, similar to findings in Millman et 
al. (2005).   
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Figure 2.  Morris Water Maze average swimming velocity at time points following mTBI treatment 
 
Figure 3.  Tail Suspension Test duration immobile at time points following mTBI treatment 
N=6 
N=7 
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From this work by our lab and others mentioned previously, we are confident that mTBI 
leads to deficit in behavioral tasks and a mechanism to describe such deficit should be 
investigated further.   
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CHAPTER 3: METHODS 
Study Design 
This study addressed the effects of mTBI on pro-inflammatory cytokine expression in the 
brain and its correlation with behavioral deficits seen in previously published experimentation 
(Milman, Rosenberg, Weizman, & Pick, 2005).  Male ICR mice (n=16), aged 8 weeks were used 
for this study. After approximately one week of acclimation, the mice were randomized into two 
groups.  The groups consisted of experimental (mTBI) subjects (n=8) and control (Sham) 
subjects (n=8). Following acclimatization period, each mouse was implanted with a mini-mitter 
probe (Mini-Mitter Vital View) into the peritoneal cavity of the mouse as a tool to accurately 
track daily cage activity.  Daily wheel running data was also collected.  Following 10 days of 
recovery following surgical implantation and baseline cage activity data collection, mTBI was 
administered to each member of the mTBI group using a protocol developed by another lab 
(Zohar, Schreiber, Getslev, Schwartz, Mullins, & Pick, 2003), while the Sham group was led 
through the same procedure without mTBI insult being administered.  48 hours following mTBI, 
mice were subjected to Roto-rod testing to ensure that any deficit in daily cage activity was not 
due to motor function damage as a result of mTBI administration but rather to lack of movement 
motivation.  Eight days following mTBI, each mouse was sacrificed.  Tissues were harvested 
immediately after sacrifice, weighed, flash frozen and stored for later analysis or pro-
inflammatory cytokine gene expression.   
Animals and Diet 
 Male ICR mice (n=16) were purchased from Jackson Laboratories (Bar Harbor, ME).  
All groups were allowed to eat ad libitum and food intake and body weight were recorded once 
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per week throughout the duration of the study.  Strict guidelines for the care and use of 
laboratory animals as directed by the National Institute of Health were followed and all 
experiments were approved by the Institutional Animal Care and Use Committee and supervised 
by the Division of Animal Resources at the University of Illinois at Urbana-Champaign.   
Mini-mitter Implantation 
 Mini Mitter Vital View probes were purchased from the Mini-Mitter Company, Inc. 
(Bend, OR).  Prior to surgery, mice were anesthetized with a sodium ketamine 
hydrochloride/xylazine hydrochloride solution (1mg and .1 mg/10g BW, ketamine:xylazine) 
injected intraperitoneally.  A toe pinch was used to determine if the quality of the anesthetic was 
adequate.  When the mice did not respond to the toe pinch, the quality of anesthetic was deemed 
adequate.  The surgical area was then cleansed with 70% ethanol and covered with a clean drape.  
Surgeons wore sterile gloves, a mask, and a clean gown and used sterile instruments.  Post 
surgical care included monitoring the mice every 15 minutes until the mice demonstrated 
alertness and mobility.  If after six hours a mouse remained unresponsive, the mouse was 
euthanized by CO2 asphyxiation.  
Measurement of Daily Cage Activity and Wheel Running 
 Following mini-mitter implantation, mice were housed in individual cages, which were 
placed on receiver/energizer pads to allow tracking of their daily cage activity and wheel running 
via mini-mitter.  Data was sent wirelessly to a computer situated in the room housing individual 
mouse cages.  Data was collected daily to observe mouse kinetics and to ensure energizer pads 
and wheels were accurately collecting data.   
Roto-rod Testing 
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To assess sensorimotor ability, mice were tested using a Roto-rod apparatus (Kinder 
Scientific, Poway, CA). Mice were placed on an elevated rod (7.0 mm in diameter) initially 
rotating at 4 rpm. Every 15 s, the rod was accelerated by 15 rpm. Fall latency was recorded by 
timers, which stopped when the mouse broke the photo-beams at the bottom of the chamber. 
Mice received three trials per day for two subsequent days. 
Cytokine Gene Expression Analysis 
 mTBI related cytokine production of Interleukin 6 (IL-6), Interleukin 1-beta (IL-1β), and 
Tumor Necrosis Factor-Alpha (TNF-α) were measured using Qiagen RNEasy mini kit.  All 
reverse transcriptase (RT) reactions were performed using an Ambion (cat#1710) reverse 
transcriptase kit according to manufacturer instructions, using 1 microgram total RNA and 
random decamer primers for each reaction.  All RNA samples were reverse transcribed 
simultaneously to minimize interassay variation associated with reverse transcription reaction.   
 Real-time RT-PCR was performed on an Applied Biosystems Prism 7900 using Taqman 
gene expression assays for TNFα (cat # Mm00443258_m1), IL-1β (cat # Mm00434228_m1) and 
IL-6 (cat # Mm00801778_m1), purchased from Applied Biosystems.  Reactions were performed 
in duplicate according to manufacturer instructions using 125 ng of cDNA template for each 
reaction.  Relative quantitative measurement of target gene levels was performed using the ΔΔCt 
method, where Ct is the threshold concentration.  GAPDH was used as the endogenous 
housekeeping control gene.   
Statistics/Data Analysis 
Cytokine expression levels were analyzed using a students t-test of variance; post-hoc 
Tukey HSD comparisons were used to determine individual group differences when a significant 
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F ratio was obtained.  Differences in Roto-Rod testing data were determined using students t-test 
with post hoc Tukey comparisons where appropriate.  All analyses were done using SPSS 
version 16.0 (Chicago, IL) and data presented as mean ± SEM.  Alpha level for main effects 
were set at p ≤ 0.05. 
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CHAPTER 4: RESULTS 
mTBI treatment induces reduced locomotor activity following treatment 
 Based on data collected from mini-mitter transmission, the mTBI treatment group had a 
reduction in overall daily cage activity and wheel running distance (determined by percentage of 
baseline, pre-treatment, wheel turn values) following mTBI treatment indicating depressive-like 
behavior.  The difference in wheel running distance (F14=6.3) and daily cage activity (F14=5.1) 
be seen graphically in Figure 4 and Figure 5 respectively.   
 
Time p=.011 
Treatment =.610 
Treatment X Time p=.290 
 
Figure 4.  Daily wheel turns collected by treatment group for 7 days following treatment.  Data expressed as a 
percentage of baseline daily wheel turns.   
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Time p=.446 
Treatment p=.878 
Treatment X Time p=.214 
 
Figure 5.  Daily cage activity of both treatment groups collected by previously implanted mini-mitter.  Data 
expressed as percentage of baseline cage activity collected prior to experimental treatment 
 
Though a difference was seen between the two treatment groups, the difference was not 
statistically significant.  Figure 6 illustrates that there was no correlation between cytokine 
expression and wheel running behavior at any day following treatment. 
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Correlations   DeltaCTIL6 Wheelrunning DeltaCTIL1B DeltaCTTNFA 
Pearson Correlation 1 .093 .686** .751** 
Sig. (2-tailed)   .763 .003 .001 DeltaCTIL6 
N 16 13 16 16 
Pearson Correlation .093 1 .197 .070 
Sig. (2-tailed) .763   .520 .820 Wheelrunning 
N 13 13 13 13 
Pearson Correlation .686** .197 1 .869** 
Sig. (2-tailed) .003 .520   .000 DeltaCTIL1B 
N 16 13 16 16 
Pearson Correlation .751** .070 .869** 1 
Sig. (2-tailed) .001 .820 .000  DeltaCTTNFA 
N 16 13 16 16 
**. Correlation is significant at the 0.01 level (2-tailed). 
Figure 6. Correlation matrix comparing pro-inflammatory cytokine expression and daily wheel running values. 
Reduced locomotor activity seen following mTBI treatment not due to motor-function deficit 
 Our data above and that of others reported that mice inflicted with mTBI demonstrated 
periods of significantly lower daily cage activity than non-mTBI cohorts following treatment 
(Milman, Rosenberg, Weizman, & Pick, 2005) (Zohar, Schreiber, Getslev, Schwartz, Mullins, & 
Pick, 2003).  Roto-rod testing was conducted at 48 and 72 hour time periods respectively 
following mTBI treatment to determine if deficit in daily cage activity seen in the mTBI cohort 
was due to lack of desire to move similar to baseline cage activity or if mTBI treatment inflicted 
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physiological motor deficit that disabled the normal movement ability of the mouse.  No 
significant difference in Roto-rod average ending speed of the rod or duration of time spent 
performing the task was observed between treatment groups.  Data is represented graphically in 
Figure 7.  This indicates that the mice were able to function normally and that they chose not to 
engage in wheel running or cage activity behavior.   
 
Figure 7.  Average End Speed (revolutions per minute) and average Duration (seconds) before completion of 
Roto-rod test for each treatment group 
Cytokine Expression Levels exhibit great variability between treatment groups and do not correlate with reduced 
activity 
 Following mTBI or SHAM treatment, only TNF-α was significantly expressed (T14=2.32; p=.036) at 
higher levels in brain tissue in the mTBI treatment group compared to the SHAM control group.  Significant 
variability was expressed in all groups when testing for the presence of all cytokines measured.  Results for cytokine 
expression in the brain can be seen in Figure 8.   
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Figure 8.  a.) shows the cytokine expression level of IL1-β in brain tissue in mTBI and SHAM treated mice.  b.) 
shows the cytokine expression of TNF-α in mTBI and SHAM treated mice.  c.) shows cytokine expression of IL-6 
in mTBI and SHAM treated mice. 
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Figure 8, continued 
c.  
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CHAPTER 5: DISCUSSION 
Findings 
 The most important finding of this study was that weight drop model of mTBI leads to 
highly variable expression of proinflammatory cytokines in brain tissue. Based on the data 
graphically represented in Figure 7, it is evident that there is a trend for up-regulation of pro-
inflammatory cytokines in brain tissue, specifically TNF-α and IL-6, but substantial variability 
amongst subjects in both treatment groups only elicited significance for levels of TNF-α in brain 
tissue.   
 It has been well established that mTBI can lead to long-term behavior and cognitive 
deficit similar to depressive-like symptoms in mice (Zohar, Schreiber, Getslev, Schwartz, 
Mullins, & Pick, 2003) (Milman, Rosenberg, Weizman, & Pick, 2005).  Encouragingly, we 
found mTBI treatment did have some effect on the test subjects, illustrated by the decrease in 
total wheel running behavior and daily cage activity, graphically depicted in Figure 4 and 5 
respectively.  Additionally, mTBI being the cause of the observed reduced motivation to run or 
move was further supported by Roto-rod testing, graphically depicted in Figure 6.  These data 
further confirm the discrepancy in cage activity and total wheel running behavior was not caused 
by neurological motor function damage due to mTBI, but rather a chosen behavior.   
 Unfortunately, as can be seen in Figure 7, there was a great deal of variability in cytokine 
expression levels of subjects in both groups following treatment.  It was expected that there 
might be a high degree of variability in cytokine expression levels amongst subjects in the mTBI 
treatment group.  It was not expected to see high cytokine expression levels in the Sham 
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treatment group.  These results indicate extenuating circumstances may have affected our results, 
or the proficiency of mTBI inflicted may not have been consistent or unreliable.   
These data support our other data demonstrating that this mTBI model failed to induce 
long-term behavioral deficits like depressive-like behavior (data not shown).  This was 
disappointing because in a published study, Milman and colleagues (2005) did demonstrate long-
term depressive-like behavior (e.g. increased immobility in tail suspension and forced swim 
tests) in a weight drop model of mTBI.  We have no explanation for the disparate findings as we 
fashioned our apparatus to mimic that of Milman et al.   
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CHAPTER 6: LIMITATIONS 
 There were a few limitations to this study.  The primary limitation is the extensive 
variability of our findings in this weight drop model.  It is our belief that the weight-drop model 
used in previous studies did not seem to reliably induce mTBI.  To reliably induce mTBI, other 
groups have invested in hydraulic apparatus in which force and location of insult administered to 
the mouse can be more accurately regulated.  Unfortunately, due to financial and time 
constraints, this more reliable model of administering mTBI was not feasible.   
 Another potential limitation to this study was small group numbers due to the loss of 
subjects in mTBI and sham experimental cohorts.  Complications with mini-mitter implantation 
surgery or significant neurological damage inflicted during mTBI resulted in the necessity for a 
small number of mice to be sacrificed, thus reducing subject numbers in all groups for our 
purposes.   
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CHAPTER 7: FUTURE DIRECTIONS 
 If future inquiries into the mechanism tying mTBI to long-term depressive like behavior 
determine that pro-inflammatory cytokines do infiltrate neural tissue and lead to modulations in 
behavior, cognition, and memory, the next step will be to determine the mechanism by which 
this response can be attenuated for more rapid recovery time for individuals who have suffered 
mTBI.   
 Recent literature investigating the effects of Traumatic Brain Injury (TBI) has revealed 
progesterone may have a significant effect in reducing the inflammatory response following TBI 
(Bhagia, et al., 2010).  Sex-differences in patients with TBI in pre-menopausal women show 
significantly lower plasma cytokine levels compared with age-matched men.  It is hypothesized 
that these sex differences in response to TBI are attributable to higher circulating levels of 
progesterone in female subjects (Bhagia, et al., 2010).   
 Recent publications have demonstrated effectiveness of progesterone in experimental 
models of TBI and may be applicable to mTBI (Frank, Pape, van Griensven, Krettek, Chaudry, 
& Hildebrand, 2007) (Malone, Kuhls, Napolitano, McCarter, & Scalea, 2001).  Research has 
consistently shown that post-injury administration of progesterone can attenuate the cytological, 
morphological, and functional behavioral and cognitive deficits caused by TBI.  One reason for 
increased survival in progesterone treated TBI patients may lie in the ability for progesterone to 
substantially reduce systemic acute-phase inflammation.  Frank et al. (2007) found that contusion 
injury to the cerebral cortex in rats induced expression of IL-1β and TNF-α in the intestinal 
mucosa, followed by apoptosis of cells in the intestinal mucosa.  A 5-day course treatment with 
P4 reduced both cytokines and cell death in the intestine, demonstrating the systemic benefits of 
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progesterone administration following TBI and may be as effective if supplemented following 
mTBI (Frank, Pape, van Griensven, Krettek, Chaudry, & Hildebrand, 2007) (Singh, 2006).   
 Progesterone is believed to have the ability to reduce inflammation after injury by 
inhibiting pro-inflammatory Th1 response and also by stimulating anti-inflammatory Th2 
immune response (Stein, Wright, & Kellermann, 2008) (Kidd, 2003).  These mechanisms are 
based on the fact that Th1/Th2 differentiation marks a decisive event very much like phase 
transition in the development of extended inflammation following insult to the periphery (Kidd, 
2003) (Singh, 2006).  This reduction in systemic inflammation may be one of the key 
mechanisms by which progesterone significantly increases survival after TBI in human subjects.  
Because TBI is essentially a massive physiological insult that leads to extreme over-activation of 
immune defense response, the introduction of stabilizing factors such as progesterone may allow 
for a reduction of this damage and increase an individuals ability to recover and may be similarly 
beneficial in mTBI (Stein, Wright, & Kellermann, 2008).   
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CHAPTER 8: SUMMARY AND CONCLUSION 
 Due to the increased prevalence and numerous health risks that accompany mTBI, 
understanding the causes and underlying physiological mechanisms that lead to long term 
depressive-like behavior as well as how to accurately diagnose and treat mTBI victims continues 
to be a high priority in current healthcare research.  Currently, researchers and clinicians have yet 
to settle on a set of diagnostic criteria that can universally be considered sufficient to diagnose an 
individual who has suffered a mTBI.  Recent research has identified a role for brain 
proinflammatory cytokine expression in mediating changes in behavior and cognition but the 
mechanistic pathway by which such cytokines may alter cognition and behavior has yet to be 
described.   
 It has been well established that mTBI causes deficits in cognitive functioning as well as 
memory and motor behavior often portrayed as depressive-like symptoms (Milman, Rosenberg, 
Weizman, & Pick, 2005) (Mittenberg, Zielinski, & Fichera, 1993) (Ettlin, et al., 1992) 
(Alexander, 1992).  Previous research has lead to the conclusion that mTBI may be a triggering 
event for a set of pathophysiological changes and such pathophysiology can be attributed to the 
presence of proinflammatory cytokines in the periphery (Ettlin, et al., 1992).  In addition, deficit 
in cognitive and behavioral learning have been identified as side effects of mTBI, likely acting 
through presence of proinflammatory cytokines in the periphery, similar to the effects of gram 
negative pathogen introduction to the physiological system (Mobayed & Dinan, 1990) 
(Povlishock & Coburn, 1989).  Given this, investigating and trying to determine the mechanism 
by which long-term depressive-like behavior is produced by examining neurological tissue for 
the presence of proinflammatory cytokines seemed like the best course of action.   
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 Data from this experiment suggest that mTBI does cause acute loss of motivation to 
perform movement 2-4 days following treatment, similar to previous unpublished data from our 
lab and published work by other groups.  Additionally, findings from this study seem to indicate 
that cytokines may be up-regulated in neurological tissue based on the significant increase 
(F14=2.32; p=.036) in TNF-α in the mTBI treatment group compared to Sham, but the variability of 
expression levels of all subjects, in both treatment groups, leads to unreliable findings.   
 If studies in the future do in fact show up-regulation of proinflammatory cytokines in 
neurological tissue, further examination into treatment and preventative measures against mTBI 
are warranted.  Specifically, an area worth researching would be with the supplementation of 
Progesterone before or after mTBI insult.  Previous research has shown that women, who 
naturally have higher levels of Progesterone expressed, may in fact have a protective 
evolutionary advantage against long-term side effects associated with mTBI. 
 In conclusion, mTBI has a significant effect on inducing depressive-like symptoms in 
subjects affecting both cognitive and behavioral learning tasks, as well as initiating depressive-
like behavioral long-term following mTBI.  The mechanism by which such behaviors are caused 
have yet to be elucidated.  More research is needed to understand this process.   
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